The FDA has implemented new rules for TV and radio drug ads, effective Nov. 20, aimed at making the advertisements more clear and direct in explaining medication risks and side effects, The Sun reported Nov. 15. 

As health systems and hospitals implement AI-powered technologies into daily workflows — such as ambient listening and drafting patient portal messages — pharmacy departments are also exploring AI's capabilities.

Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13. 

A six-month shortage of cisplatin, a drug used in the treatment of head and neck cancer, resulted in a 16% total cost increase for practices in the U.S. Oncology Network, according to a study presented Sept. 27-28, at the American…

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated with tirzepatide remained diabetes-free by the end of the…

The FDA continues to face significant staffing shortages in its drug inspection workforce, according to a new report from the Government Accountability Office. 

The FDA has rejected the supplemental new drug application for Ocaliva, a treatment for primary biliary cholangitis, a rare liver disease. 

As retail pharmacy giants such as CVS, Walgreens and Rite Aid close stores across the U.S., the consequences for patient care and the impact on the pharmacy industry are becoming more apparent. 

Here are nine new drug shortages to know, according to databases compiled by the FDA and the American Society of Health-System Pharmacists. 

Novavax received clearance from the FDA to move forward with phase 3 clinical trials for its COVID-19-influenza combination (CIC) and standalone influenza vaccines.